These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 6862137

  • 1. [Experimental morphological study, using electron microscopy, of adriamycin-induced cardiomyopathy].
    Accardo G, Aleotti A, Pazzi A, Tampieri ML, Zennaro A, Casaro S.
    G Clin Med; 1983; 64(1-2):1-11. PubMed ID: 6862137
    [No Abstract] [Full Text] [Related]

  • 2. Abrogation of adriamycin-induced cardiotoxicity by selenium in rabbits.
    Dimitrov NV, Hay MB, Siew S, Hudler DA, Charamella LJ, Ullrey DE.
    Am J Pathol; 1987 Feb; 126(2):376-83. PubMed ID: 3826299
    [Abstract] [Full Text] [Related]

  • 3. [Morphological manifestations of anthracycline cardiomyopathy in the ventricular myocardium of the rat].
    Semenov DE, Nepomniashchikh LM, Semenova LA.
    Biull Eksp Biol Med; 1987 Jul; 104(7):113-6. PubMed ID: 3620638
    [Abstract] [Full Text] [Related]

  • 4. Adriamycin-induced cardiomyopathy. A rat model.
    Czarnecki A, Hinek A, Sołtysiak-Pawluczuk D.
    Pol J Pharmacol Pharm; 1986 Jul; 38(2):171-7. PubMed ID: 3748888
    [Abstract] [Full Text] [Related]

  • 5. Effects of L-carnitine on adriamycin-induced cardiomyopathy in rabbit.
    Paterna S, Furitano G, Scaffidi L, Barbarino C, Campisi D, Parisi G, Carreca I.
    Int J Tissue React; 1984 Jul; 6(1):91-5. PubMed ID: 6715123
    [Abstract] [Full Text] [Related]

  • 6. Adriamycin effect on histological, histochemical and electron microscopy changes in rat myocardium.
    Wutzen J, Lewicki Z, Rózycka Z.
    Mater Med Pol; 1986 Jul; 18(4):191-7. PubMed ID: 3613678
    [No Abstract] [Full Text] [Related]

  • 7. [Intracellular reorganization and ultrastructural stereologic analysis of cardiomyocytes from W/SSM rats with genetically determined cardiomyopathy].
    Lushnikova EL, Nepomniashchikh LM, Postnikova OA, Tsimmerman VG.
    Biull Eksp Biol Med; 1999 Aug; 127(8):233-7. PubMed ID: 11188753
    [No Abstract] [Full Text] [Related]

  • 8. [Stereological analysis of ultrastructural changes in cardiomyocytes during adriblastina-induced cardiomyopathy].
    Nurmukhambetov AN, Ivanov AP.
    Biull Eksp Biol Med; 1986 Jul; 102(7):92-4. PubMed ID: 3730602
    [Abstract] [Full Text] [Related]

  • 9. Post mortem, ultrastructural cardiac muscle changes and anthracycline toxicity.
    Andersson B, Collins VP.
    Biomed Pharmacother; 1983 Jul; 37(6):281-7. PubMed ID: 6367847
    [Abstract] [Full Text] [Related]

  • 10. [Ultrastructure and metabolic heterogeneity of cardiomyocytes in acute myocardial injury during aging].
    Nepomniashchikh LM, Lushnikova EL, Chernokalova MG, Tumanov VP.
    Biull Eksp Biol Med; 1982 Oct; 94(10):119-23. PubMed ID: 6184086
    [No Abstract] [Full Text] [Related]

  • 11. Morphological study of acute myocardial lesions experimentally induced by methamphetamine.
    Kaiho M, Ishiyama I.
    Nihon Hoigaku Zasshi; 1989 Dec; 43(6):460-8. PubMed ID: 2636278
    [Abstract] [Full Text] [Related]

  • 12. A comparative electron microscopic study of aclacinomycin and adriamycin cardiotoxicities in rabbits and hamsters.
    Wakabayashi T, Oki T, Tone H, Hirano S, Omori K.
    J Electron Microsc (Tokyo); 1980 Dec; 29(2):106-18. PubMed ID: 6933206
    [No Abstract] [Full Text] [Related]

  • 13. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.
    Xiang P, Deng HY, Li K, Huang GY, Chen Y, Tu L, Ng PC, Pong NH, Zhao H, Zhang L, Sung RY.
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):343-9. PubMed ID: 18379782
    [Abstract] [Full Text] [Related]

  • 14. Carnitine protection against adriamycin-induced cardiomyopathy in rats.
    McFalls EO, Paulson DJ, Gilbert EF, Shug AL.
    Life Sci; 1986 Feb 10; 38(6):497-505. PubMed ID: 3945174
    [Abstract] [Full Text] [Related]

  • 15. Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187.
    Zhang J, Clark JR, Herman EH, Ferrans VJ.
    J Mol Cell Cardiol; 1996 Sep 10; 28(9):1931-43. PubMed ID: 8899552
    [Abstract] [Full Text] [Related]

  • 16. [Ultrastructure of the myocardium in experimental autoimmune cardiomyopathy].
    Sharov VG, Vikhert AM.
    Arkh Patol; 1976 Sep 10; 38(5):27-34. PubMed ID: 1023848
    [Abstract] [Full Text] [Related]

  • 17. Doxorubicin (adriamycin) cardiomyopathy.
    Saltiel E, McGuire W.
    West J Med; 1983 Sep 10; 139(3):332-41. PubMed ID: 6356608
    [Abstract] [Full Text] [Related]

  • 18. [Chronic toxicities of adriamycin (ADR) and their possible prevention by coenzyme Q10 and verapamil in rabbits--especially ADR induced cardiomyopathy (author's transl)].
    Dohmae N, Sawada H, Tashima M, Uchino H, Matsuyama E, Konishi T.
    Nihon Gan Chiryo Gakkai Shi; 1979 Oct 20; 14(6):1009-28. PubMed ID: 541529
    [No Abstract] [Full Text] [Related]

  • 19. Differential expression of HSP70 and ultrastructure of heart and liver tissues of rats treated with adriamycin: protective role of L-carnitine.
    Strauss M, Porras N.
    Invest Clin; 2007 Mar 20; 48(1):33-43. PubMed ID: 17432542
    [Abstract] [Full Text] [Related]

  • 20. Lack of the protective effect of solcoseryl on adriamycin-induced cardiomyopathy in rats.
    Danysz A, Czarnecki A, Hinek A.
    Acta Pol Pharm; 1986 Mar 20; 43(5):504-9. PubMed ID: 3565049
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.